COVID19 infection in a patient undergoing treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH) with Ravulizumab

被引：0
作者：
Sufana Shikdar
Azra Borogovac
Elabdallah Mohamad
Mohamad Khawandanah
机构：
[1] University of Oklahoma Health Sciences Center,Department of Hematology/Oncology, Stephenson Cancer Center
[2] University of Oklahoma Medical Center (OUMC),Department of Internal Medicine
[3] University of Oklahoma Health Sciences Center,Hematology/Oncology fellow, Department of Medicine, Division of Hematology
来源：
Thrombosis Journal | / 19卷
关键词：
COVID19; Paroxysmal nocturnal hemoglobinuria; Complement inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 87 条
  • [61] Urwyler P(undefined)undefined undefined undefined undefined-undefined
  • [62] Charitos P(undefined)undefined undefined undefined undefined-undefined
  • [63] Moser S(undefined)undefined undefined undefined undefined-undefined
  • [64] Heijnen IA(undefined)undefined undefined undefined undefined-undefined
  • [65] Trendelenburg M(undefined)undefined undefined undefined undefined-undefined
  • [66] Thoma R(undefined)undefined undefined undefined undefined-undefined
  • [67] Sumer J(undefined)undefined undefined undefined undefined-undefined
  • [68] Camacho-Ortiz A(undefined)undefined undefined undefined undefined-undefined
  • [69] Bacci MR(undefined)undefined undefined undefined undefined-undefined
  • [70] Huber LC(undefined)undefined undefined undefined undefined-undefined
123456789